PALISADE BIO, INC.
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
TERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On July 25, 2025, we issued 8,637,810 common stock purchase warrants. The shares of common stock issuable upon the exercise of these warrants were unregistered at the time of issuance, but have subsequently been registered by the Company pursuant to Form S-3 (File Number 333-289635) declared effective by the SEC on August 28, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.